Our Capabilities

Support your decisions with analytical rigor and custom insights


Corporate Strategy and
Franchise Planning

In both steady and tumultuous times, it’s critical for any organization to establish a clear strategic plan for growth and investment.

Kx Advisors works with executive teams responsible for developing and managing these strategies at the company and franchise level. We do this by objectively and quantitatively assessing the business’s current growth trajectory based on assets both in market and in development.

We then identify and prioritize organic and inorganic opportunities to develop long-term strategies for success—whether seeking to establish an innovative new offering, reinvigorate a mature business, or mitigate impending threats.

Example projects may include:

  • Portfolio assessment and prioritization
  • Franchise plan development
  • Market entry strategy
  • Market and competitive landscape assessments
  • Acquisition target identification and screening
  • M&A and licensing due diligence
  • Wargaming and scenario planning

Market Expansion and

One of the most powerful advantages a company can have is capturing new growth opportunities within existing markets.

Market expansion for medical technologies can be driven by many factors in healthcare—new sites of service, new healthcare provider groups, expanding market access, and new addressable patient populations.

Kx Advisors thrives in helping clients identify and quantify the business potential for these emerging market trends, and build strategies to seize these opportunities ahead of the competition.

Example projects may include:

  • Customer white space and adjacency strategies
  • Market opportunity assessments
  • Channel strategy optimization
  • New sites-of-service strategies
  • Target patient population expansion

Mergers and
Acquisitions (M&A)

Value drivers for life sciences deals are affected by complex externalities.  Successful healthcare mergers and acquisitions (M&A) require due diligence that extends beyond high-level benchmarks.

Kx Advisors combines real-world experience and deep analysis to address the rapidly evolving complexities of the life sciences industry in today’s healthcare deal landscape.

Example projects may include:

  • Target identification and screening
    • Investment criteria and theses
    • Financial profiles
    • Short-list screening
  • Pre-diligence assessment
    • Business model stability
    • Threshold questions
    • Market definition
    • Value proposition assessment
  • Commercial due diligence assessment
    • Customer satisfaction
    • Competitive landscape analysis
    • Market opportunity assessment
    • Regulatory and risk of disruption
    • Revenue forecasts
    • Synergy valuation
  • Post-acquisition value creation
    • Corporate and franchise planning
    • Integration planning
    • Market expansion and forecasting
    • New product planning

New Product

Bringing a new product to market begins with a foundation of detailed planning and analysis often years in advance of launch.

Kx Advisors’ new product planning capabilities enable our clients to better understand market dynamics, areas of differentiation, and strategic tradeoffs to optimize a product’s profile and adoption.

We offer tailored solutions at all stages of product development to support the depth of analysis required for key strategic decisions to unlock value.

Example projects may include:

  • Product forecasting
  • Target product profile optimization
  • Value proposition development
  • Indication and market prioritization
  • Patient journey mapping
  • Customer segmentation and targeting
  • Competitive intelligence and share capture
  • Product positioning and testing
  • Pricing and reimbursement analysis

Pricing and
Market Access

In both reimbursed and cash-pay markets, pricing alone can make or break the lifetime value of a product or service.

With the paradigm shift towards value-based care and fee-for-value reimbursement, the need for thoughtful and innovative pricing and market access strategies is paramount.

Kx Advisors’ capabilities enable our clients to leverage pricing as a tool to maximize the inherent value of their portfolios, to anticipate and adapt to competitive pricing dynamics, and to better understand and contextualize global market access structures.

Example projects may include:

  • Drug and device pricing strategy development
  • Procedural economic modeling for medical devices
  • International reference drug pricing analyses
  • Payer policy and coverage quality strategies
  • Capital equipment and consumables pricing
  • Gross-to-net discount optimization
  • Business model development for software and services

Brand Planning and
Launch Strategy

Successfully creating and launching new brands is a crucial driver of growth, yet it’s common for new products to fall short of forecasted expectations. In a healthcare environment where there’s often too much information, standing out amongst a crowd and remaining top of mind continues to challenge new brands.

As products in the pipeline move from clinical development to marketing, translating a product profile and clinical data into positioning, tactics, and sales execution requires detailed cross-functional planning.

Kx Advisors helps companies establish differentiated brands — advising on strategies for brand positioning and messaging, targeting, promotion mix, sales operations, and launch monitoring to ensure rapid adoption.

Example projects may include:

  • Brand positioning and messaging
  • Marketing investment and mix planning
  • Launch readiness and monitoring
  • Commercial operations strategy and benchmarking
  • Customer segmentation and targeting
  • Wargaming and scenario planning